United Capital Financial Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$135K Buy
+22,481
New +$169K ﹤0.01% 1579
2025
Q4
Sell
-16,352
Closed -$175K 1396
2025
Q3
$175K Buy
+16,352
New +$160K ﹤0.01% 1175
2025
Q2
Sell
-10,069
Closed -$150K 1120
2025
Q1
$150K Buy
+10,069
New +$155K ﹤0.01% 1033
2024
Q4
Sell
-11,051
Closed -$211K 1091
2024
Q3
$211K Sell
11,051
-421
-4% -$8.73K ﹤0.01% 991
2024
Q2
$237K Sell
11,472
-569
-5% -$11.3K ﹤0.01% 930
2024
Q1
$226K Buy
12,041
+644
+6% +$11.1K ﹤0.01% 979
2023
Q4
$164K Buy
+11,397
New +$155K ﹤0.01% 1016
2022
Q4
Sell
-9,927
Closed -$232K 1090
2022
Q3
$232K Sell
9,927
-540
-5% -$16.3K ﹤0.01% 977
2022
Q2
$353K Sell
10,467
-1,022
-9% -$35.8K ﹤0.01% 895
2022
Q1
$401K Sell
11,489
-1,156
-9% -$39.5K ﹤0.01% 902
2021
Q4
$385K Sell
12,645
-5,195
-29% -$169K ﹤0.01% 939
2021
Q3
$585K Sell
17,840
-17,851
-50% -$571K ﹤0.01% 819
2021
Q2
$1.08M Buy
+35,691
New +$1.17M 0.01% 672

Other funds holding OGN

United Capital Financial Advisors's OGN Position: Q1 2026 in Review

United Capital Financial Advisors opened a new position in Organon & Co (OGN) in Q1 2026: 22,481 shares worth $135K. The stake represents ﹤0.01% of the portfolio and ranks #1579 among its holdings. This is a return to the name: United Capital Financial Advisors previously reported a position in OGN as recently as Q3 2025.

United Capital Financial Advisors first reported a position in OGN in Q2 2021 and has held it in 13 quarters since. The position peaked at $1.08M in Q2 2021. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • United Capital Financial Advisors held 22,481 shares of Organon & Co worth $135K as of Q1 2026.
  • Organon & Co was a new United Capital Financial Advisors position in Q1 2026.
  • Organon & Co made up ﹤0.01% of United Capital Financial Advisors's portfolio in Q1 2026, its #1579 holding.
  • United Capital Financial Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 13 quarters since.
  • United Capital Financial Advisors's Organon & Co position peaked at $1.08M in Q2 2021.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on United Capital Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.